Trevor J. Stedke, Senior Vice President of Operations at Frontier Group Holdings, Inc., filed a Form 4 on November 9, 2026, disclosing the sale of 34,180 shares of common stock on November 6, 2026.
General Dynamics Corp Chairman and CEO Phebe N. Novakovic filed a Form 4 on November 9, 2026, disclosing the sale of 45,353 shares of General Dynamics common stock on November 5, 2026, across six transactions at weighted average prices ranging from $360.052 to $365.605 …
An amended ownership statement for Evelyn D'An, a director of Matinas BioPharma Holdings, Inc. (NYSE:MTNB), was filed on November 9, 2026, correcting an administrative error in the previously reported exercise price of a stock option granted on November 6, 2026.
Director Edward Neugeboren of Matinas BioPharma Holdings, Inc. filed an amended ownership statement on November 9, 2026, correcting an administrative error in the reported exercise price of a stock option granted on November 6, 2026.
Simon van den Born, President of Marex Group Ltd, filed a Form 4 on November 9, 2026, disclosing the sale of 22,456 ordinary shares on November 5, 2026, executed under a pre-established Rule 10b5-1 trading plan.
Finance of America Companies Inc. Chief Investment Officer Jeremy Prahm filed a Form 4 on November 9, 2026, disclosing the sale of 6,000 shares of Class A Common Stock on November 5, 2026, pursuant to a Rule 10b5-1 trading plan.
An amended ownership statement for Keith Murphy, a director of Matinas BioPharma Holdings, Inc. (NYSE:MTNB), was filed on November 9, 2026, to correct the reported exercise price of a stock option granted on November 6, 2026.
Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., filed a Form 4 on November 9, 2026, disclosing a disposition of 1,505 shares of common stock on November 6, 2026, to satisfy tax withholding obligations connected to the vesting of restricted stock units.
Vericel Corp Chief Financial Officer Joseph Anthony Mara Jr filed a Form 4 on November 9, 2026, disclosing the exercise of stock options and sale of common stock across four transactions on November 5-6, 2026, pursuant to a Rule 10b5-1 trading plan.
Director Chris Lavern Reed of Byrna Technologies Inc. was granted 25,848 restricted stock units on November 7, 2026, as reported in a beneficial ownership filing submitted to the SEC on November 9, 2026.